abstract |
The present disclosure describes novel PRMT5 inhibitors and methods of preparing them. Pharmaceutical compositions containing such PRMT5 inhibitors, as well as methods of using them to treat cancer, infections, and other PRMT5-related disorders are also described. [Selection diagram] None |